Sponsors: []Modifications: ; and(iii)  facilitate providing controlled substance prescription information to a third partyunder Subsection (5).(5) (a)  An individual may request that the division send the information underSubsection (5)(b) to a third party who is designated by the individual each time a controlledsubstance prescription for the individual is dispensed.(b)  The information the division shall provide under Subsection (5)(a) is:(i)  the fact a controlled substance has been dispensed to the individual, but withoutidentifying the controlled substance; and(ii)  the date the controlled substance was dispensed.(6)Full text:



1     CONTROLLED SUBSTANCE PRESCRIPTION2     NOTIFICATION3     2016 GENERAL SESSION4     STATE OF UTAH5     Chief Sponsor:  Brad M. Daw6     Senate Sponsor:   Curtis S. Bramble7      8     LONG TITLE9     General Description:10          This bill modifies provisions regarding controlled substances.11     Highlighted Provisions:12          This bill:13                amends the Controlled Substance Database Act to allow a person for whom a14     controlled substance is prescribed to designate a third party who is to be notified15     when a controlled substance prescription is dispensed to the person; and16                authorizes the division to make administrative rules to facilitate implementation of17     this provision.18     Money Appropriated in this Bill:19          None20     Other Special Clauses:21          None22     Utah Code Sections Affected:23     AMENDS:24          58-37f-301, as last amended by Laws of Utah 2015, Chapters 89, 326, and 33625      26     Be it enacted by the Legislature of the state of Utah:27          Section 1.  Section 58-37f-301 is amended to read:28          58-37f-301. Access to database.29          (1)  The division shall make rules, in accordance with Title 63G, Chapter 3, Utah30     Administrative Rulemaking Act, to:31          (a)  effectively enforce the limitations on access to the database as described in this32     part; and33          (b)  establish standards and procedures to ensure accurate identification of individuals34     requesting information or receiving information without request from the database.35          (2)  The division shall make information in the database and information obtained from36     other state or federal prescription monitoring programs by means of the database available only37     to the following individuals, in accordance with the requirements of this chapter and division38     rules:39          (a)  personnel of the division specifically assigned to conduct investigations related to40     controlled substance laws under the jurisdiction of the division;41          (b)  authorized division personnel engaged in analysis of controlled substance42     prescription information as a part of the assigned duties and responsibilities of their43     employment;44          (c)  in accordance with a written agreement entered into with the department,45     employees of the Department of Health:46          (i)  whom the director of the Department of Health assigns to conduct scientific studies47     regarding the use or abuse of controlled substances, if the identity of the individuals and48     pharmacies in the database are confidential and are not disclosed in any manner to any49     individual who is not directly involved in the scientific studies; or50          (ii)  when the information is requested by the Department of Health in relation to a51     person or provider whom the Department of Health suspects may be improperly obtaining or52     providing a controlled substance;53          (d)  in accordance with a written agreement entered into with the department, a54     designee of the director of the Department of Health, who is not an employee of the55     Department of Health, whom the director of the Department of Health assigns to conduct56     scientific studies regarding the use or abuse of controlled substances pursuant to an application57     process established in rule by the Department of Health, if:58          (i)  the designee provides explicit information to the Department of Health regarding59     the purpose of the scientific studies;60          (ii)  the scientific studies to be conducted by the designee:61          (A)  fit within the responsibilities of the Department of Health for health and welfare;62          (B)  are reviewed and approved by an Institutional Review Board that is approved for63     human subject research by the United States Department of Health and Human Services; and64          (C)  are not conducted for profit or commercial gain; and65          (D)  are conducted in a research facility, as defined by division rule, that is associated66     with a university or college in the state accredited by one or more regional or national67     accrediting agencies recognized by the United States Department of Education;68          (iii)  the designee protects the information as a business associate of the Department of69     Health; and70          (iv)  the identity of the prescribers, patients, and pharmacies in the database are71     de-identified, confidential, not disclosed in any manner to the designee or to any individual72     who is not directly involved in the scientific studies;73          (e)  in accordance with the written agreement entered into with the department and the74     Department of Health, authorized employees of a managed care organization, as defined in 4275     C.F.R. Sec. 438, if:76          (i)  the managed care organization contracts with the Department of Health under the77     provisions of Section 26-18-405 and the contract includes provisions that:78          (A)  require a managed care organization employee who will have access to information79     from the database to submit to a criminal background check; and80          (B) limit the authorized employee of the managed care organization to requesting either81     the division or the Department of Health to conduct a search of the database regarding a82     specific Medicaid enrollee and to report the results of the search to the authorized employee;83     and84          (ii)  the information is requested by an authorized employee of the managed care85     organization in relation to a person who is enrolled in the Medicaid program with the managed86     care organization, and the managed care organization suspects the person may be improperly87     obtaining or providing a controlled substance;88          (f)  a licensed practitioner having authority to prescribe controlled substances, to the89     extent the information:90          (i) (A)  relates specifically to a current or prospective patient of the practitioner; and91          (B)  is provided to or sought by the practitioner for the purpose of:92          (I)  prescribing or considering prescribing any controlled substance to the current or93     prospective patient;94          (II)  diagnosing the current or prospective patient;95          (III)  providing medical treatment or medical advice to the current or prospective96     patient; or97          (IV)  determining whether the current or prospective patient:98          (Aa)  is attempting to fraudulently obtain a controlled substance from the practitioner;99     or100          (Bb)  has fraudulently obtained, or attempted to fraudulently obtain, a controlled101     substance from the practitioner;102          (ii) (A)  relates specifically to a former patient of the practitioner; and103          (B)  is provided to or sought by the practitioner for the purpose of determining whether104     the former patient has fraudulently obtained, or has attempted to fraudulently obtain, a105     controlled substance from the practitioner;106          (iii)  relates specifically to an individual who has access to the practitioner's Drug107     Enforcement Administration identification number, and the practitioner suspects that the108     individual may have used the practitioner's Drug Enforcement Administration identification109     number to fraudulently acquire or prescribe a controlled substance;110          (iv)  relates to the practitioner's own prescribing practices, except when specifically111     prohibited by the division by administrative rule;112          (v)  relates to the use of the controlled substance database by an employee of the113     practitioner, described in Subsection (2)(g); or114          (vi)  relates to any use of the practitioner's Drug Enforcement Administration115     identification number to obtain, attempt to obtain, prescribe, or attempt to prescribe, a116     controlled substance;117          (g)  in accordance with Subsection (3)(a), an employee of a practitioner described in118     Subsection (2)(f), for a purpose described in Subsection (2)(f)(i) or (ii), if:119          (i)  the employee is designated by the practitioner as an individual authorized to access120     the information on behalf of the practitioner;121          (ii)  the practitioner provides written notice to the division of the identity of the122     employee; and123          (iii)  the division:124          (A)  grants the employee access to the database; and125          (B)  provides the employee with a password that is unique to that employee to access126     the database in order to permit the division to comply with the requirements of Subsection127     58-37f-203(5) with respect to the employee;128          (h)  an employee of the same business that employs a licensed practitioner under129     Subsection (2)(f) if:130          (i)  the employee is designated by the practitioner as an individual authorized to access131     the information on behalf of the practitioner;132          (ii)  the practitioner and the employing business provide written notice to the division of133     the identity of the designated employee; and134          (iii)  the division:135          (A)  grants the employee access to the database; and136          (B)  provides the employee with a password that is unique to that employee to access137     the database in order to permit the division to comply with the requirements of Subsection138     58-37f-203(5) with respect to the employee;139          (i)  a licensed pharmacist having authority to dispense a controlled substance to the140     extent the information is provided or sought for the purpose of:141          (i)  dispensing or considering dispensing any controlled substance; or142          (ii)  determining whether a person:143          (A)  is attempting to fraudulently obtain a controlled substance from the pharmacist; or144          (B)  has fraudulently obtained, or attempted to fraudulently obtain, a controlled145     substance from the pharmacist;146          (j)  in accordance with Subsection (3)(a), a licensed pharmacy technician and pharmacy147     intern who is an employee of a pharmacy as defined in Section 58-17b-102, for the purposes148     described in Subsection (2)(h)(i) or (ii), if:149          (i)  the employee is designated by the pharmacist-in-charge as an individual authorized150     to access the information on behalf of a licensed pharmacist employed by the pharmacy;151          (ii)  the pharmacist-in-charge provides written notice to the division of the identity of152     the employee; and153          (iii)  the division:154          (A)  grants the employee access to the database; and155          (B)  provides the employee with a password that is unique to that employee to access156     the database in order to permit the division to comply with the requirements of Subsection157     58-37f-203(5) with respect to the employee;158          (k)  pursuant to a valid search warrant, federal, state, and local law enforcement159     agencies and state and local prosecutors that are engaged in an investigation related to:160          (i)  one or more controlled substances; and161          (ii)  a specific person who is a subject of the investigation;162          (l)  employees of the Office of Internal Audit and Program Integrity within the163     Department of Health who are engaged in their specified duty of ensuring Medicaid program164     integrity under Section 26-18-2.3;165          (m)  a mental health therapist, if:166          (i)  the information relates to a patient who is:167          (A)  enrolled in a licensed substance abuse treatment program; and168          (B)  receiving treatment from, or under the direction of, the mental health therapist as169     part of the patient's participation in the licensed substance abuse treatment program described170     in Subsection (2)(m)(i)(A);171          (ii)  the information is sought for the purpose of determining whether the patient is172     using a controlled substance while the patient is enrolled in the licensed substance abuse173     treatment program described in Subsection (2)(m)(i)(A); and174          (iii)  the licensed substance abuse treatment program described in Subsection175     (2)(m)(i)(A) is associated with a practitioner who:176          (A)  is a physician, a physician assistant, an advance practice registered nurse, or a177     pharmacist; and178          (B)  is available to consult with the mental health therapist regarding the information179     obtained by the mental health therapist, under this Subsection (2)(m), from the database;180          (n)  an individual who is the recipient of a controlled substance prescription entered into181     the database, upon providing evidence satisfactory to the division that the individual requesting182     the information is in fact the individual about whom the data entry was made;183          (o)  an individual under Subsection (2)(n) for the purpose of obtaining a list of the184     persons and entities that have requested or received any information from the database185     regarding the individual, except if the individual's record is subject to a pending or current186     investigation as authorized under this Subsection (2);187          (p)  the inspector general, or a designee of the inspector general, of the Office of188     Inspector General of Medicaid Services, for the purpose of fulfilling the duties described in189     Title 63A, Chapter 13, Part 2, Office and Powers; and190          (q)  the following licensed physicians for the purpose of reviewing and offering an191     opinion on an individual's request for workers' compensation benefits under Title 34A, Chapter192     2, Workers' Compensation Act, or Title 34A, Chapter 3, Utah Occupational Disease Act:193          (i)  a member of the medical panel described in Section 34A-2-601;194          (ii)  a physician employed as medical director for a licensed workers' compensation195     insurer or an approved self-insured employer; or196          (iii)  a physician offering a second opinion regarding treatment.197          (3) (a) (i)  A practitioner described in Subsection (2)(f) may designate up to three198     employees to access information from the database under Subsection (2)(g), (2)(h), or (4)(c).199          (ii)  A pharmacist described in Subsection (2)(i) who is a pharmacist-in-charge may200     designate up to five employees to access information from the database under Subsection (2)(j).201          (b)  The division shall make rules, in accordance with Title 63G, Chapter 3, Utah202     Administrative Rulemaking Act, to:203          (i)  establish background check procedures to determine whether an employee204     designated under Subsection (2)(g), (2)(h), or (4)(c) should be granted access to the database;205     [and]206          (ii)  establish the information to be provided by an emergency room employee under207     Subsection (4)[.]; and208          (iii)  facilitate providing controlled substance prescription information to a third party209     under Subsection (5).210          (c)  The division shall grant an employee designated under Subsection (2)(g), (2)(h), or211     (4)(c) access to the database, unless the division determines, based on a background check, that212     the employee poses a security risk to the information contained in the database.213          (4) (a)  An individual who is employed in the emergency room of a hospital may214     exercise access to the database under this Subsection (4) on behalf of a licensed practitioner if215     the individual is designated under Subsection (4)(c) and the licensed practitioner:216          (i)  is employed in the emergency room;217          (ii)  is treating an emergency room patient for an emergency medical condition; and218          (iii)  requests that an individual employed in the emergency room and designated under219     Subsection (4)(c) obtain information regarding the patient from the database as needed in the220     course of treatment.221          (b)  The emergency room employee obtaining information from the database shall,222     when gaining access to the database, provide to the database the name and any additional223     identifiers regarding the requesting practitioner as required by division administrative rule224     established under Subsection (3)(b).225          (c)  An individual employed in the emergency room under this Subsection (4) may226     obtain information from the database as provided in Subsection (4)(a) if:227          (i)  the employee is designated by the practitioner as an individual authorized to access228     the information on behalf of the practitioner;229          (ii)  the practitioner and the hospital operating the emergency room provide written230     notice to the division of the identity of the designated employee; and231          (iii)  the division:232          (A)  grants the employee access to the database; and233          (B)  provides the employee with a password that is unique to that employee to access234     the database in order to permit the division to comply with the requirements of Subsection235     58-37f-203(5) with respect to the employee.236          (d)  The division may impose a fee, in accordance with Section 63J-1-504, on a237     practitioner who designates an employee under Subsection (2)(g), (2)(h), or (4)(c) to pay for the238     costs incurred by the division to conduct the background check and make the determination239     described in Subsection (3)(b).240          (5) (a)  An individual may request that the division send the information under241     Subsection (5)(b) to a third party who is designated by the individual each time a controlled242     substance prescription for the individual is dispensed.243          (b)  The information the division shall provide under Subsection (5)(a) is:244          (i)  the fact a controlled substance has been dispensed to the individual, but without245     identifying the controlled substance; and246          (ii)  the date the controlled substance was dispensed.247          [(5)] (6) (a)  An individual who is granted access to the database based on the fact that248     the individual is a licensed practitioner or a mental health therapist shall be denied access to the249     database when the individual is no longer licensed.250          (b)  An individual who is granted access to the database based on the fact that the251     individual is a designated employee of a licensed practitioner shall be denied access to the252     database when the practitioner is no longer licensed.Legislative Review NoteOffice of Legislative Research and General Counsel

